1 / 5

The Rising Transactional Fervor in Cell Therapies: Exploring Breakthroughs

In the past few years, the field of cell therapies has witnessed substantial transactional fervor, whereby living cells are employed to cure diseases. The impetus behind this wave of activity can be attributed in part to the breakthroughs in the regenerative medicine arena, which aims to utilize the intrinsic healing capabilities of the human body to tackle an array of ailments.<br>https://biointel360.com

Bio8
Download Presentation

The Rising Transactional Fervor in Cell Therapies: Exploring Breakthroughs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Rising Transactional Fervor in Cell Therapies: Exploring Breakthroughs In the past few years, the field of cell therapies has witnessed substantial transactional fervor, whereby living cells are employed to cure diseases. The impetus behind this wave of activity can be attributed in part to the breakthroughs in the regenerative medicine arena, which aims to utilize the intrinsic healing capabilities of the human body to tackle an array of ailments. Cell therapieshave shown promise in treating a variety of diseases, including cancer, autoimmune disorders, and cardiovascular diseases.

  2. BioIntel360

  3. Read more: Cell and Gene Therapy: Current and Future Prospects One such example is the acquisition of Kite Pharma, a leading CAR-T therapy company, by Gilead Sciences for $11.9 billion in 2017. Another example is the partnership between Novartis and the University of Pennsylvania to develop CAR-T therapies for cancer. The growing interest in cell therapies has also led to an increase in funding for research and development in this area.

  4. Read more: From bench to bedside: The impact of manufacturing advances on the cell and gene therapy market BioIntel360suggests that the significant potential of cell therapies has triggered a flurry of deal activity in the biotech industry over the past few years. As research continues to advance in this field, it is probable that there will be an upsurge in mergers, acquisitions, and partnerships aimed at cell therapies in the future.

  5. Contact Us info@biointel360.com + 1 (813) 694-7124 http://biointel360.com/

More Related